点击图片查看原图
肾上腺髓质素受体抗体
组蛋白赖氨酸N-甲基转移酶2B抗体
C-藻蓝素/藻蓝蛋白/藻
抗菌肽/天蚕素抗体
叶绿体伴侣蛋白抗体
AHA3抗体（拟南芥）
小鼠抗Bcl-6单克隆抗
醋酸戈那瑞林
人胎盘羊膜间充质干细
谷草转氨酶（CAS:9000Rabbit Anti-phospho-IKB epsilon (Ser157) antibody
| 产品编号 | hz-5517R |
| 英文名称 | phospho-IKB epsilon (Ser157) |
| 中文名称 | ***酸化KB抑制蛋白激酶ε |
| 别 名 | NFKBIE (phospho S157); IKB epsilon (phospho-Ser157); IKB epsilon (phospho-S); p-IKB epsilon (phospho-Ser157); p-IKB epsilon (S157); I kappa B epsilon; IkappaBepsilon; IkB E; IKBE; IKB epsilon; MGC72568; NF kappa B inhibitor epsilon; NF kappa BIE; NFkappa BIE; NFkappaB inhibitor epsilon; NFKBIE; Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor epsilon; OTTHUMP00000016522; Slc35b2; solute carrier family 35, member B2. |
| 产品类型 | ***酸化抗体 |
| 研究领域 | 免疫学 信号转导 转录调节因子 激酶和***酸酶 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | Human, Cow, |
| 产品应用 | WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 IF=1:100-500 （石蜡切片需做抗原修复） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 55kDa |
| 细胞定位 | 细胞浆 |
| 性 状 | Lyophilized or Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthesised phosphopeptide derived from human NFKBIE around the phosphorylation site of Ser157:YD(p-S)GI |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存条件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| PubMed | PubMed |
| 产品介绍 | background: NFKB1 or NFKB2 is bound to REL, RELA, or RELB to form the NFKB complex. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA, or NFKBIB), which inactivate NF-kappa-B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA, or IKBKB) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T; R is an A or G purine; and Y is a C or T pyrimidine). For some genes, activation requires NFKB interaction with other transcription factors, such as STAT, AP1 (JUN), and NFAT. Function: nhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. Inhibits DNA-binding of NF-kappa-B p50-p65 and p50-c-Rel complexes. Subunit: nteracts with RELA, REL, NFKB1 nuclear factor NF-kappa-B p50 subunit and NFKB2 nuclear factor NF-kappa-B p52 subunit. Subcellular Location: Cytoplasm. Tissue Specificity: Highly expressed in spleen, testis and lung, followed by kidney, pancreas, heart, placenta and brain. Also expressed in granulocytes and macrophages. Post-translational modifications: Serine phosphorylated; followed by proteasome-dependent degradation. Similarity: Belongs to the NF-kappa-B inhibitor family. Contains 6 ANK repeats. SWISS: O00221 Gene ID: 4794 Database links: Entrez Gene: 4794 Human Entrez Gene: 18037 Mouse Entrez Gene: 316241 Rat Omim: 604548 Human SwissProt: O00221 Human SwissProt: O54910 Mouse Unigene: 458276 Human Unigene: 57043 Mouse Unigene: 129334 Rat Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications |
